As part of our evaluation of members of TM4SF as possible prognostic predictors, we further extended our study to the expression of CD151 and performed a retrospective study on the expression of CD151, MRP-1/CD9 and KAI1/CD82 in colon cancer. This evidence concerns the gene CD9 and colonic neoplasm.